2013
DOI: 10.1074/jbc.m113.493221
|View full text |Cite
|
Sign up to set email alerts
|

Mutation for Nonsyndromic Mental Retardation in the trans-2-Enoyl-CoA Reductase TER Gene Involved in Fatty Acid Elongation Impairs the Enzyme Activity and Stability, Leading to Change in Sphingolipid Profile

Abstract: Background: The P182L mutation in the trans-2-enoyl-CoA reductase (TER) gene required for very long-chain fatty acid (VLCFA) synthesis causes nonsyndromic mental retardation. Results: This mutation reduces the activity and stability of the TER enzyme. Conclusion:The impaired TER function affects VLCFA synthesis and thereby alters the cellular sphingolipid profile. Significance: Maintenance of a proper VLCFA level may be important for neural function.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(27 citation statements)
references
References 31 publications
1
26
0
Order By: Relevance
“…Implicitly, this indicates that ELOVL1‐7 interact with the other enzymes, KAR, TER, and HACD1‐4, in the fatty acid chain elongation system to form the elongase complex . Among the elongase complex, KAR, which catalyzes the first reduction step in elongation system (reducing 3‐ketoacyl‐CoA to 3‐hydroxyacyl‐CoA) following the ELOVL1‐7‐mediated condensation step in mammals , could enhance ELOVL6 activity in both KAR‐dependent and KAR‐independent manner ; KER, catalyzing the second reduction step following HACD1‐4‐mediated dehydration, may indirectly affect HACD1‐4 performance as well . Since ELOVL1‐7 catalyze the first and rate‐limiting step in elongation system, and are overexpressed to a similar extent in this study, we only take ELOVL1‐7, but not the whole elongase complex into consideration.…”
Section: Discussionmentioning
confidence: 99%
“…Implicitly, this indicates that ELOVL1‐7 interact with the other enzymes, KAR, TER, and HACD1‐4, in the fatty acid chain elongation system to form the elongase complex . Among the elongase complex, KAR, which catalyzes the first reduction step in elongation system (reducing 3‐ketoacyl‐CoA to 3‐hydroxyacyl‐CoA) following the ELOVL1‐7‐mediated condensation step in mammals , could enhance ELOVL6 activity in both KAR‐dependent and KAR‐independent manner ; KER, catalyzing the second reduction step following HACD1‐4‐mediated dehydration, may indirectly affect HACD1‐4 performance as well . Since ELOVL1‐7 catalyze the first and rate‐limiting step in elongation system, and are overexpressed to a similar extent in this study, we only take ELOVL1‐7, but not the whole elongase complex into consideration.…”
Section: Discussionmentioning
confidence: 99%
“…CerS expression does not always correspond to SL chain length profiles, possibly a result of post-translational modifications (Laviad et al, 2008(Laviad et al, , 2012 or substrate availability (Abe et al, 2013). Recently, homo-or heterodimer CerS formation was demonstrated experimentally and the dimerization roles played by CerS are being investigated (Mesicek et al, 2010;Laviad et al, 2012).…”
Section: Cers Regulationmentioning
confidence: 99%
“…As far as the third isoform of testosterone α-reductase (SRD5A3, also known as polyprenol reductase), available data report recovery from the microsomal fraction [8] and transient expression in HeLa cells yielded cytoplasmic localization, and no detectable activity [36] . For the TECR enzyme, immunohistochemistry has clearly suggested a localization in the ER [12] . No data is available for the TECRL that has been described only at the gene level.…”
Section: Discussionmentioning
confidence: 99%
“…Trans-2-Enoyl-CoA reductase (TER or TECR) comes as a more recent addition to the SRD5A family. This gene, when mutated, causes a rare autosomic syndrome, nonsyndromic mental retardation, and the protein carries out the fourth step of very long-chain fatty acid synthesis and sphingosine degradation [12] . TECR expression seems ubiquitous in man and mouse organs by Northern blot analysis [13] , with high expression in the nervous system [14] consistently with its involvement in the synthesis of membrane lipids and with congenital neurological impairment arising from mutations.…”
Section: Introductionmentioning
confidence: 99%